• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾小球损伤分子-1 在糖尿病肾小球病变中的肾小球表达和足细胞减少。

Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.

机构信息

Department of Physiology, Morehouse School of Medicine, Atlanta, GA 30310, USA.

出版信息

Am J Nephrol. 2011;34(3):268-80. doi: 10.1159/000330187. Epub 2011 Aug 4.

DOI:10.1159/000330187
PMID:21822010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3169370/
Abstract

BACKGROUND/AIMS: Studies have shown that kidney injury molecule-1 (KIM-1) is upregulated in damaged renal proximal tubules. In this study, we examined KIM-1 expression in glomerular epithelial cells in diabetic glomerulopathy.

METHODS

Renal histology, immunostaining and Western blot for protein level, and real-time PCR for mRNA expression of KIM-1 and podocyte markers were evaluated in untreated or losartan-treated Zucker lean (Fa/+) and Zucker diabetic fatty (Fa/Fa) rats.

RESULTS

The diabetic rats showed an increased glomerular expression of KIM-1. KIM-1 staining was localized primarily in the hyperplastic parietal epithelium of Bowman's capsule in the early stages of diabetes with subsequent increase in KIM-1-positive cells in the glomerular tuft in the more advanced stages. The increase in glomerular KIM-1 was associated with a decrease in podocytes in Fa/Fa rats. Antiproteinuric treatment with losartan attenuated podocytopenia and decreased renal expression of KIM-1 in treated diabetic rats. In an in vitro study, albumin overload increased KIM-1 protein in the primary cultures of rat glomerular epithelial cells.

CONCLUSION

These results show that glomerular KIM-1 expression was increased, in proportion to the extent of proteinuria and podocytopenia in the diabetic animals, supporting that KIM-1 could be used as a potential biomarker for glomerular injury in proteinuric kidney disease.

摘要

背景/目的:研究表明,肾损伤分子-1(KIM-1)在受损的肾近端小管中上调。在本研究中,我们研究了糖尿病肾小球病变中肾小球上皮细胞中 KIM-1 的表达。

方法

在未治疗或氯沙坦治疗的 Zucker 瘦(Fa/ +)和 Zucker 糖尿病肥胖(Fa/Fa)大鼠中评估肾组织学、免疫染色和蛋白质水平的 Western blot 以及 KIM-1 和足细胞标志物的实时 PCR 表达。

结果

糖尿病大鼠的肾小球 KIM-1 表达增加。KIM-1 染色主要定位于糖尿病早期 Bowman 囊的增生壁细胞,随后在更晚期的肾小球丛中 KIM-1 阳性细胞增加。肾小球 KIM-1 的增加与 Fa/Fa 大鼠足细胞减少有关。用氯沙坦进行抗蛋白尿治疗可减轻糖尿病大鼠的足细胞减少并降低肾脏 KIM-1 的表达。在一项体外研究中,白蛋白超负荷增加了大鼠肾小球上皮细胞原代培养物中的 KIM-1 蛋白。

结论

这些结果表明,肾小球 KIM-1 的表达随着糖尿病动物蛋白尿和足细胞减少的程度而增加,支持 KIM-1 可作为蛋白尿性肾病肾小球损伤的潜在生物标志物。

相似文献

1
Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.肾小球损伤分子-1 在糖尿病肾小球病变中的肾小球表达和足细胞减少。
Am J Nephrol. 2011;34(3):268-80. doi: 10.1159/000330187. Epub 2011 Aug 4.
2
Matrix metalloproteinase-9 expression is enhanced in renal parietal epithelial cells of zucker diabetic Fatty rats and is induced by albumin in in vitro primary parietal cell culture.基质金属蛋白酶-9在Zucker糖尿病脂肪大鼠的肾壁层上皮细胞中表达增强,且在体外原代壁层细胞培养中由白蛋白诱导表达。
PLoS One. 2015 Apr 7;10(4):e0123276. doi: 10.1371/journal.pone.0123276. eCollection 2015.
3
Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.足细胞损伤促进Zucker糖尿病脂肪大鼠的进行性肾病。
Lab Invest. 2002 Jan;82(1):25-35. doi: 10.1038/labinvest.3780392.
4
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.导致伴有II型糖尿病的肥胖 Zucker(脂肪)大鼠肾损伤的早期事件。
Kidney Int. 2000 Jan;57(1):167-82. doi: 10.1046/j.1523-1755.2000.00836.x.
5
Glomerular parietal epithelial cell activation induces collagen secretion and thickening of Bowman's capsule in diabetes.肾小球壁层上皮细胞的激活可导致糖尿病时胶原分泌和鲍曼囊增厚。
Lab Invest. 2015 Mar;95(3):273-82. doi: 10.1038/labinvest.2014.160. Epub 2014 Dec 22.
6
Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and Inflammatory Response.肾损伤分子 1 在肾脂毒性中上调,并介导棕榈酸诱导的肾小管细胞损伤和炎症反应。
Int J Mol Sci. 2019 Jul 11;20(14):3406. doi: 10.3390/ijms20143406.
7
Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease.链脲佐菌素诱导的糖尿病大鼠肾小球细胞(足细胞)凋亡增加:在糖尿病肾小球疾病发展中的作用
Diabetologia. 2007 Dec;50(12):2591-9. doi: 10.1007/s00125-007-0821-y. Epub 2007 Sep 28.
8
Up-regulation of connexin43 in glomerular podocytes in response to injury.肾小球足细胞中连接蛋白43响应损伤而上调。
Am J Pathol. 2002 Nov;161(5):1597-606. doi: 10.1016/s0002-9440(10)64438-0.
9
Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.实验性糖尿病肾病中肾小球囊壁层上皮细胞Gas1的表达
Histochem Cell Biol. 2017 Jul;148(1):33-47. doi: 10.1007/s00418-017-1550-z. Epub 2017 Mar 18.
10
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.血管紧张素II受体阻滞剂抑制葡萄糖刺激的足细胞和糖尿病肾小球中p27Kip1的表达。
Kidney Int. 2005 Mar;67(3):944-52. doi: 10.1111/j.1523-1755.2005.00158.x.

引用本文的文献

1
Administration of Purified Alpha-1 Antitrypsin in Salt-Loaded Hypertensive 129Sv Mice Attenuates the Expression of Inflammatory Associated Proteins in the Kidney.给盐负荷高血压129Sv小鼠注射纯化的α-1抗胰蛋白酶可减轻肾脏中炎症相关蛋白的表达。
Biomolecules. 2025 Jun 30;15(7):951. doi: 10.3390/biom15070951.
2
New and Emerging Biomarkers in Chronic Kidney Disease.慢性肾脏病中的新型和新兴生物标志物
Biomedicines. 2025 Jun 10;13(6):1423. doi: 10.3390/biomedicines13061423.
3
KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance.在正常白蛋白尿的2型糖尿病和胰岛素抵抗患者中,Kim-1作为肾小管损伤的生物标志物。
J Bras Nefrol. 2025 Jul-Sep;47(3):e20240123. doi: 10.1590/2175-8239-JBN-2024-0123en.
4
Cellular phenotypic transitions in diabetic nephropathy: An update.糖尿病肾病中的细胞表型转变:最新进展
Front Pharmacol. 2022 Nov 2;13:1038073. doi: 10.3389/fphar.2022.1038073. eCollection 2022.
5
Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial.钠-葡萄糖协同转运蛋白 2(SGLT2)抑制剂卡格列净对肾小管炎症和损伤作用机制的事后中介分析:CANVAS 试验。
Diabetes Obes Metab. 2022 Oct;24(10):1950-1956. doi: 10.1111/dom.14779. Epub 2022 Jun 28.
6
The Role of Parietal Epithelial Cells in the Pathogenesis of Podocytopathy.壁层上皮细胞在足细胞病发病机制中的作用
Front Physiol. 2022 Mar 11;13:832772. doi: 10.3389/fphys.2022.832772. eCollection 2022.
7
Examining the factors contributing to the association between non-albuminuric CKD and a low rate of kidney function decline in diabetes.探究导致非白蛋白尿性慢性肾脏病与糖尿病患者肾功能低下降率之间关联的因素。
Ther Adv Endocrinol Metab. 2022 Mar 25;13:20420188221083518. doi: 10.1177/20420188221083518. eCollection 2022.
8
Kidney Injury Molecule-1 and Periostin Urinary Excretion and Tissue Expression Levels and Association with Glomerular Disease Outcomes.肾损伤分子-1和骨膜蛋白的尿排泄及组织表达水平与肾小球疾病预后的关系
Glomerular Dis. 2021 Jun;1(2):45-59. doi: 10.1159/000513166. Epub 2021 Mar 30.
9
A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies.慢性肾损伤特异性生物标志物的研究进展及其在非临床安全性评价研究中的潜在应用。
Toxicol Pathol. 2021 Jul;49(5):996-1023. doi: 10.1177/0192623320985045. Epub 2021 Feb 12.
10
Enteropeptidase inhibition improves kidney function in a rat model of diabetic kidney disease.肠肽酶抑制可改善糖尿病肾病大鼠模型的肾功能。
Diabetes Obes Metab. 2021 Jan;23(1):86-96. doi: 10.1111/dom.14190. Epub 2020 Oct 6.

本文引用的文献

1
Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model.达贝泊汀-α 治疗可增强 Thy-1 肾小球肾炎模型中的肾小球再生过程。
Am J Physiol Renal Physiol. 2010 Dec;299(6):F1278-87. doi: 10.1152/ajprenal.00343.2009. Epub 2010 Sep 8.
2
Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy.非诺贝特通过抑制核因子-κB 和转化生长因子-β1/Smad3 减轻糖尿病肾病的肾小管间质纤维化和炎症。
Exp Biol Med (Maywood). 2010 Mar;235(3):383-91. doi: 10.1258/ebm.2009.009218.
3
De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.在实验性肾小球疾病中,壁层上皮细胞中足细胞蛋白的从头表达。
Am J Physiol Renal Physiol. 2010 Mar;298(3):F702-11. doi: 10.1152/ajprenal.00428.2009. Epub 2009 Dec 9.
4
The podocyte in diabetic kidney disease.糖尿病肾病中的足细胞。
ScientificWorldJournal. 2009 Oct 14;9:1127-39. doi: 10.1100/tsw.2009.133.
5
A new function for parietal epithelial cells: a second glomerular barrier.壁层上皮细胞的新功能:第二个肾小球屏障。
Am J Physiol Renal Physiol. 2009 Dec;297(6):F1566-74. doi: 10.1152/ajprenal.00214.2009. Epub 2009 Sep 30.
6
Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.在细胞性/塌陷性局灶节段性肾小球硬化小鼠模型中,基因标记的足细胞谱系显示足细胞进行性减少伴壁层细胞增生。
Am J Pathol. 2009 May;174(5):1675-82. doi: 10.2353/ajpath.2009.080789. Epub 2009 Apr 9.
7
Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more.肾损伤分子-1(KIM-1):一种尿液生物标志物及更多功能。
Nephrol Dial Transplant. 2009 Nov;24(11):3265-8. doi: 10.1093/ndt/gfp010. Epub 2009 Mar 23.
8
Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time.随着时间的推移,阿霉素诱导的肾病中蛋白尿的减少与肾损伤分子(Kim-1)的减少有关。
Am J Physiol Renal Physiol. 2009 May;296(5):F1136-45. doi: 10.1152/ajprenal.00541.2007. Epub 2009 Feb 18.
9
Assay validation for KIM-1: human urinary renal dysfunction biomarker.KIM-1的检测验证:人尿肾功能障碍生物标志物
Int J Biol Sci. 2009;5(2):128-34. doi: 10.7150/ijbs.5.128. Epub 2009 Jan 19.
10
Recruitment of podocytes from glomerular parietal epithelial cells.从肾小球壁层上皮细胞募集足细胞。
J Am Soc Nephrol. 2009 Feb;20(2):333-43. doi: 10.1681/ASN.2008070795. Epub 2008 Dec 17.